19/06/2025
Do You or Someone You Know Struggle with Treatment-Resistant Depression?
atai Therapeutics Inc. is researching an investigational treatment that includes DMT, a psychedelic compound, combined with psychological support.
This study is designed for individuals with major depression who have not responded to traditional antidepressant treatments. By participating, you may gain access to a potential new approach under the care of experienced clinical researchers.
Reimbursement is available for up to $960.
To learn more and check your eligibility, visit our website: 👉 https://centreforneurologystudies.com/psychedelic-compound-dmt-for-treatment-resistant-depression/